Commure operates in healthcare ai / operations software. The latest valuation stands at $7B (post-money). The stock is not listed on any public market.
2 valuations. The latest, $7B post-money, was set by the Series Funding in May 2026.
General CatalystLEADCommure is an AI-native healthcare operations company headquartered in Mountain View, California, that automates clinical documentation, patient intake and revenue-cycle work for health systems. Its Ambient AI product is an AI-powered clinical documentation platform that automates notes, coding and workflows, while Commure Agents handle tasks such as patient engagement, care coordination and billing.
The company keeps growing offices in Utah, Los Angeles, New York and Brazil alongside its Mountain View headquarters, and in 2026 its valuation reached $7 billion following fresh funding.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Commure.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Commure availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Commure included.
The routes section explains what is realistically available for a company at this stage.
No. Commure is a private company; its shares do not trade on a public exchange.
The last valuation is $7B (post-money, May 2026).
Lead investors for each round are in the funding timeline.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
